MTOR and autoimmune thrombocytopenic purpura: SRL, an mTOR inhibitor, has been used broadly for immune suppression after organ transplantation or hematopoietic stem cell transplantation (21, 22), but few groups have reported its efficacy in ITP therapy (12).